AMBBY
Price
$15.35
Change
-$0.42 (-2.66%)
Updated
Sep 22 closing price
Capitalization
3.88B
VTAK
Price
$2.58
Change
+$0.23 (+9.79%)
Updated
Sep 29, 04:56 PM (EDT)
Capitalization
3.5M
Interact to see
Advertisement

AMBBY vs VTAK

Header iconAMBBY vs VTAK Comparison
Open Charts AMBBY vs VTAKBanner chart's image
Ambu A/S
Price$15.35
Change-$0.42 (-2.66%)
Volume$100
Capitalization3.88B
Catheter Precision
Price$2.58
Change+$0.23 (+9.79%)
Volume$1.47K
Capitalization3.5M
AMBBY vs VTAK Comparison Chart in %
Loading...
AMBBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMBBY vs. VTAK commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBBY is a Hold and VTAK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 30, 2025
Stock price -- (AMBBY: $15.35 vs. VTAK: $2.35)
Brand notoriety: AMBBY and VTAK are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AMBBY: 5% vs. VTAK: 5%
Market capitalization -- AMBBY: $3.88B vs. VTAK: $3.5M
AMBBY [@Medical/Nursing Services] is valued at $3.88B. VTAK’s [@Medical/Nursing Services] market capitalization is $3.5M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.44B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMBBY’s FA Score shows that 0 FA rating(s) are green whileVTAK’s FA Score has 2 green FA rating(s).

  • AMBBY’s FA Score: 0 green, 5 red.
  • VTAK’s FA Score: 2 green, 3 red.
According to our system of comparison, VTAK is a better buy in the long-term than AMBBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMBBY’s TA Score shows that 3 TA indicator(s) are bullish while VTAK’s TA Score has 2 bullish TA indicator(s).

  • AMBBY’s TA Score: 3 bullish, 4 bearish.
  • VTAK’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, AMBBY is a better buy in the short-term than VTAK.

Price Growth

AMBBY (@Medical/Nursing Services) experienced а -2.66% price change this week, while VTAK (@Medical/Nursing Services) price change was -2.08% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.67%. For the same industry, the average monthly price growth was +2.62%, and the average quarterly price growth was +10.35%.

Industries' Descriptions

@Medical/Nursing Services (-2.67% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMBBY($3.88B) has a higher market cap than VTAK($3.5M). AMBBY has higher P/E ratio than VTAK: AMBBY (73.32) vs VTAK (0.07). AMBBY YTD gains are higher at: 17.896 vs. VTAK (-72.576). AMBBY has higher annual earnings (EBITDA): 830M vs. VTAK (-15.46M). AMBBY has more cash in the bank: 751M vs. VTAK (1.71M). VTAK has less debt than AMBBY: VTAK (3.66M) vs AMBBY (534M). AMBBY has higher revenues than VTAK: AMBBY (5.96B) vs VTAK (600K).
AMBBYVTAKAMBBY / VTAK
Capitalization3.88B3.5M110,987%
EBITDA830M-15.46M-5,367%
Gain YTD17.896-72.576-25%
P/E Ratio73.320.07104,928%
Revenue5.96B600K993,000%
Total Cash751M1.71M43,867%
Total Debt534M3.66M14,574%
FUNDAMENTALS RATINGS
AMBBY vs VTAK: Fundamental Ratings
AMBBY
VTAK
OUTLOOK RATING
1..100
5018
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
82100
PRICE GROWTH RATING
1..100
7895
P/E GROWTH RATING
1..100
533
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTAK's Valuation (30) in the Medical Specialties industry is significantly better than the same rating for AMBBY (98) in the null industry. This means that VTAK’s stock grew significantly faster than AMBBY’s over the last 12 months.

VTAK's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AMBBY (100) in the null industry. This means that VTAK’s stock grew similarly to AMBBY’s over the last 12 months.

AMBBY's SMR Rating (82) in the null industry is in the same range as VTAK (100) in the Medical Specialties industry. This means that AMBBY’s stock grew similarly to VTAK’s over the last 12 months.

AMBBY's Price Growth Rating (78) in the null industry is in the same range as VTAK (95) in the Medical Specialties industry. This means that AMBBY’s stock grew similarly to VTAK’s over the last 12 months.

VTAK's P/E Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for AMBBY (53) in the null industry. This means that VTAK’s stock grew somewhat faster than AMBBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMBBYVTAK
RSI
ODDS (%)
Bearish Trend 4 days ago
54%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
51%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
62%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMBBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDDIX21.680.29
+1.36%
13D Activist I
PSMVX12.080.13
+1.09%
Principal SmallCap Value II R6
CAVYX17.530.11
+0.63%
SEI Catholic Values Equity Y (SCVT)
BSCFX30.190.16
+0.55%
Baron Small Cap Retail
FBGKX257.030.79
+0.31%
Fidelity Blue Chip Growth K

AMBBY and

Correlation & Price change

A.I.dvisor tells us that AMBBY and AZTA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMBBY and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMBBY
1D Price
Change %
AMBBY100%
N/A
AZTA - AMBBY
24%
Poorly correlated
-0.66%
CLPBY - AMBBY
23%
Poorly correlated
+0.59%
GNNDY - AMBBY
23%
Poorly correlated
N/A
ALGN - AMBBY
23%
Poorly correlated
+1.05%
VTAK - AMBBY
21%
Poorly correlated
+3.98%
More

VTAK and

Correlation & Price change

A.I.dvisor tells us that VTAK and PRPO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTAK and PRPO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTAK
1D Price
Change %
VTAK100%
+3.98%
PRPO - VTAK
27%
Poorly correlated
-2.52%
BLFS - VTAK
25%
Poorly correlated
+2.15%
SGHT - VTAK
25%
Poorly correlated
+1.46%
CSTL - VTAK
25%
Poorly correlated
-0.13%
CERS - VTAK
25%
Poorly correlated
-4.64%
More